Israel Active

The expiry date printed on many medicine bottles is not relevant once you open it – you must record the date it was opened. Israel’s Innocap has a special cap with a simple dial that records the day and month of opening. It also connects to a smartphone which displays information about the medicine.

Israeli NGO Startup Nation Central is helping Tzafon Medical Center (Poriya hospital) near Tiberias become a regional leader in health tech innovation and entrepreneurship. It will also support the new Helmsley Rehabilitation Center at the hospital.

Sharsheret Israel helps English-speaking women in Israel with breast cancer to navigate treatment and support. Based on the US model, Sharsheret Israel is piloting its services including psychosocial support, cancer treatment navigation, education, support groups and more.

Israeli NGO The Protective Partnership has started a free one-day retreat in Herzliya, called the Villa. Led by Dr Ronny Simons, it uses Eye movement desensitization and reprocessing (EMDR) therapy to strengthen the brains of IDF soldiers to protect against suffering PTSD.

Researchers from The Hebrew University of Jerusalem have identified the brain’s claustrum as vital for controlling behaviour e.g., responsiveness and impulsivity. It also regulates sleep and the new knowledge can open up new pathways for treating ADHD, schizophrenia, OCD, and addictions.

Israel’s AccuLine is developing CORA – an accurate, non-invasive, swift, and low-cost test for early detection of coronary artery disease and prevent heart attacks. It detects 2 novel bio-signals in combination with AI-powered signal processing and proprietary augmented waveform display.

Israel’s HAGAR’s GWave is the world's first non-invasive continuous glucose monitoring technology that uses radiofrequency (RF) waves to measure glucose levels in the blood. Its latest trial had 97% accuracy compared to blood tests (see ). See other Israeli monitors .

Israel’s BioGenCell (see previously) is conducting Phase 2 trials of its Tissue Regenerative Activated Cell (TRACT) Therapy. It is preventing amputations at Netanya’s Laniado Medical Center, the US (Yale and Johns Hopkins), Belgium, and Georgia. It is now raising funds for Phase 3 trials.

Israel’s BioGenCell (see previously) is conducting Phase 2 trials of its Tissue Regenerative Activated Cell (TRACT) Therapy. It is preventing amputations at Netanya’s Laniado Medical Center, the US (Yale and Johns Hopkins), Belgium, and Georgia. It is now raising funds for Phase 3 trials.

Cleveland based University Hospitals is deploying the aiOS diagnosis platform from Israel’s Aidoc (see previously) across 13 of its hospitals and many outpatient locations. All patients undergoing CT scans for injury or pain will be analyzed by aiOS for expected and unusual conditions.